Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
Sponsor: Regeneron Pharmaceuticals
Summary
A long-term observational registry in patients with atopic dermatitis (AD) initiating treatment with DUPIXENT® (dupilumab)
Official title: A Prospective Observational Study of Patients Receiving DUPIXENT® for Atopic Dermatitis
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
858
Start Date
2018-04-06
Completion Date
2027-03-30
Last Updated
2025-12-29
Healthy Volunteers
No
Conditions
Interventions
Dupilumab
Dupixent 1 dose at Baseline required for eligibility; otherwise, no therapeutic intervention required during the course of the study. In addition to (or substituting for) DUPIXENT®, participants may receive marketed drugs as deemed necessary by their physicians for the treatment of AD or comorbid conditions.
Locations (99)
Regeneron Investigational Site
Birmingham, Alabama, United States
Regeneron Investigational Site
Gilbert, Arizona, United States
Regeneron Investigational Site
Fountain Valley, California, United States
Regeneron Investigational Site
Laguna Hills, California, United States
Regeneron Investigational Site
Loma Linda, California, United States
Regeneron Investigational Site
Los Angeles, California, United States
Regeneron Investigational Site
Los Angeles, California, United States
Regeneron Investigational Site
Manhattan Beach, California, United States
Regeneron Investigational Site
Newport Beach, California, United States
Regeneron Investigational Site
Oceanside, California, United States
Regeneron Investigational Site
Redondo Beach, California, United States
Regeneron Investigational Site
Riverside, California, United States
Regeneron Investigational Site
Roseville, California, United States
Regeneron Investigational Site
San Diego, California, United States
Regeneron Investigational Site
Santa Monica, California, United States
Regeneron Investigational Site
Thousand Oaks, California, United States
Regeneron Investigational Site
New Haven, Connecticut, United States
Regeneron Investigational Site
Coral Gables, Florida, United States
Regeneron Investigational Site
Margate, Florida, United States
Regeneron Investigational Site
West Palm Beach, Florida, United States
Regeneron Investigational Site
Atlanta, Georgia, United States
Regeneron Investigational Site
Macon, Georgia, United States
Regeneron Investigational Site
Marietta, Georgia, United States
Regeneron Investigational Site
Marietta, Georgia, United States
Regeneron Investigational Site
Sandy Springs, Georgia, United States
Regeneron Investigational Site
Champaign, Illinois, United States
Regeneron Investigational Site
Chicago, Illinois, United States
Regeneron Investigational Site
La Grange Park, Illinois, United States
Regeneron Investigational Site
Skokie, Illinois, United States
Regeneron Investigational Site
Springfield, Illinois, United States
Regeneron Investigational Site
Fort Wayne, Indiana, United States
Regeneron Investigational Site
Plainfield, Indiana, United States
Regeneron Investigational Site
Overland Park, Kansas, United States
Regeneron Investigational Site
Corbin, Kentucky, United States
Regeneron Investigational Site
Louisville, Kentucky, United States
Regeneron Investigational Site
Rockville, Maryland, United States
Regeneron Investigational Site
Towson, Maryland, United States
Regeneron Investigational Site
Upper Marlboro, Maryland, United States
Regeneron Investigational Site
White Marsh, Maryland, United States
Regeneron Investigational Site
Quincy, Massachusetts, United States
Regeneron Investigational Site
Ann Arbor, Michigan, United States
Regeneron Investigational Site
Bay City, Michigan, United States
Regeneron Investigational Site
Troy, Michigan, United States
Regeneron Investigational Site
Warren, Michigan, United States
Regeneron Investigational Site
Columbia, Missouri, United States
Regeneron Investigational Site
Kirksville, Missouri, United States
Regeneron Investigational Site
St Louis, Missouri, United States
Regeneron Investigational Site
Lincoln, Nebraska, United States
Regeneron Investigational Site
Henderson, Nevada, United States
Regeneron Investigational Site
Las Vegas, Nevada, United States
Regeneron Investigational Site
Brick, New Jersey, United States
Regeneron Investigational Site
East Windsor, New Jersey, United States
Regeneron Investigational Site
Edison, New Jersey, United States
Regeneron Investigational Site
Piscataway, New Jersey, United States
Regeneron Investigational Site
Elmhurst, New York, United States
Regeneron Investigational Site
Forest Hills, New York, United States
Regeneron Investigational Site
Garden City, New York, United States
Regeneron Investigational Site
Kew Gardens, New York, United States
Regeneron Investigational Site
Lake Success, New York, United States
Regeneron Investigational Site
Manhasset, New York, United States
Regeneron Investigational Site
Mineola, New York, United States
Regeneron Investigational Site
Mount Vernon, New York, United States
Regeneron Investigational Site
New York, New York, United States
Regeneron Investigational Site
New York, New York, United States
Regeneron Investigational Site
New York, New York, United States
Regeneron Investigational Site
New York, New York, United States
Regeneron Investigational Site
The Bronx, New York, United States
Regeneron Investigational Site
Troy, New York, United States
Regeneron Investigational Site
Concord, North Carolina, United States
Regeneron Investigational Site
Akron, Ohio, United States
Regeneron Investigational Site
Athens, Ohio, United States
Regeneron Investigational Site
Bexley, Ohio, United States
Regeneron Investigational Site
Marion, Ohio, United States
Regeneron Investigational Site
Mason, Ohio, United States
Regeneron Investigational Site
Tulsa, Oklahoma, United States
Regeneron Investigational Site
Portland, Oregon, United States
Regeneron Investigational Site
Blue Bell, Pennsylvania, United States
Regeneron Investigational Site
Philadelphia, Pennsylvania, United States
Regeneron Investigational Site
Philadelphia, Pennsylvania, United States
Regeneron Investigational Site
Sellersville, Pennsylvania, United States
Regeneron Investigational Site
Yardley, Pennsylvania, United States
Regeneron Investigational Site
Charleston, South Carolina, United States
Regeneron Investigational Site
North Charleston, South Carolina, United States
Regeneron Investigational Site
Bellaire, Texas, United States
Regeneron Investigational Site
Dallas, Texas, United States
Regeneron Investigational Site
Grapevine, Texas, United States
Regeneron Investigational Site
San Antonio, Texas, United States
Regeneron Investigational Site
Sugar Land, Texas, United States
Regeneron Investigational Site
Sugar Land, Texas, United States
Regeneron Investigational Site
Arlington, Virginia, United States
Regeneron Investigational Site
Norfolk, Virginia, United States
Regeneron Investigational Site
Bellevue, Washington, United States
Regeneron Investigational Site
Milwaukee, Wisconsin, United States
Regeneron Investigational Site
Hamilton, Ontario, Canada
Regeneron Investigational Site
Markham, Ontario, Canada
Regeneron Investigational Site
Ottawa, Ontario, Canada
Regeneron Investigational Site
Peterborough, Ontario, Canada
Regeneron Investigational Site
Toronto, Ontario, Canada
Regeneron Investigational Site
Québec, Canada